![Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire](https://mms.businesswire.com/media/20170907005441/en/610835/5/Melanoma_Data_Chart_.jpg)
Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire
![Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825817307709-gr4.jpg)
Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect
![A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer | British Journal of Cancer A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-01050-w/MediaObjects/41416_2020_1050_Fig1_HTML.png)
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer | British Journal of Cancer
![Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825817307709-gr2.jpg)
Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect
![Comparison of objective response rate (ORR) according to the presence... | Download Scientific Diagram Comparison of objective response rate (ORR) according to the presence... | Download Scientific Diagram](https://www.researchgate.net/profile/Marek-Minarik-2/publication/233973088/figure/fig2/AS:300090855051265@1448558643733/ECOG-Performance-Status-at-the-time-of-diagnosis_Q320.jpg)
Comparison of objective response rate (ORR) according to the presence... | Download Scientific Diagram
![Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825817307709-gr3.jpg)
Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers | PLOS ONE
![A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer | British Journal of Cancer A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-020-01050-w/MediaObjects/41416_2020_1050_Fig4_HTML.png)
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer | British Journal of Cancer
![PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/31979901b045184c8053075e4956319c5588d33c/5-Table2-1.png)
PDF] Objective response rate assessment in oncology: Current situation and future expectations | Semantic Scholar
![The analysis of objective response rate (ORR) between 2 groups based on... | Download Scientific Diagram The analysis of objective response rate (ORR) between 2 groups based on... | Download Scientific Diagram](https://www.researchgate.net/publication/340921387/figure/fig3/AS:903486497624066@1592419375208/The-analysis-of-objective-response-rate-ORR-between-2-groups-based-on-tumor-sites.png)
The analysis of objective response rate (ORR) between 2 groups based on... | Download Scientific Diagram
![Comparison of objective response rate (ORR) according to the presence... | Download Scientific Diagram Comparison of objective response rate (ORR) according to the presence... | Download Scientific Diagram](https://www.researchgate.net/profile/Marek-Minarik-2/publication/233973088/figure/fig5/AS:300090859245568@1448558644138/Comparison-of-progression-free-survival-PFS-in-patients-without-EGFR-mutation-treated_Q320.jpg)
Comparison of objective response rate (ORR) according to the presence... | Download Scientific Diagram
![The analysis of objective response rate (ORR) between 2 groups based on... | Download Scientific Diagram The analysis of objective response rate (ORR) between 2 groups based on... | Download Scientific Diagram](https://www.researchgate.net/publication/340921387/figure/fig3/AS:903486497624066@1592419375208/The-analysis-of-objective-response-rate-ORR-between-2-groups-based-on-tumor-sites_Q320.jpg)